Detalhe da pesquisa
1.
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials.
JCO Precis Oncol
; 7: e2200509, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37027812
2.
Patient-centered trials in oncology: Time for a change.
Med
; 3(7): 445-449, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809559
3.
When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.
Target Oncol
; 17(3): 253-270, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687223
4.
Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials.
Eur J Cancer
; 173: 167-177, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872510
5.
A risk stratification model for toxicities in phase 1 immunotherapy trials.
Eur J Cancer
; 175: 11-18, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36084619
6.
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil.
JTO Clin Res Rep
; 3(10): 100402, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36193188
7.
Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era.
Eur J Cancer
; 158: 85-98, 2021 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656816
8.
Beyond immune checkpoint blockade: emerging immunological strategies.
Nat Rev Drug Discov
; 20(12): 899-919, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686237
9.
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events.
Curr Oncol
; 28(3): 2173-2179, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208089
10.
Systematic SARS-CoV-2-testing for asymptomatic cancer patients treated at a public healthcare tertiary centre in Brazil.
Ecancermedicalscience
; 15: 1269, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34567254
11.
Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics.
Cancer Treat Rev
; 92: 102125, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33227623
12.
Genomic Landscape of Malignant Peripheral Nerve Sheath TumorâLike Melanoma.
J Invest Dermatol
; 141(10): 2470-2479, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831431
13.
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus.
Cancers (Basel)
; 14(1)2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008256
14.
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy.
JNCI Cancer Spectr
; 5(3)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056539
15.
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 13(14)2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298857
16.
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.
J Geriatr Oncol
; 12(5): 820-826, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674246
17.
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599023
18.
Designing circulating tumor DNA-based interventional clinical trials in oncology.
Genome Med
; 11(1): 22, 2019 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31003596
19.
Complete metastasectomy in renal cell carcinoma: a propensity-score matched by the International Metastatic RCC Database Consortium prognostic model.
Ecancermedicalscience
; 13: 967, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921338
20.
The Day After COVID-19-Time to Rethink Oncology Clinical Research.
JAMA Oncol
; 7(1): 23-24, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32880604